A detailed history of Monashee Investment Management LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Monashee Investment Management LLC holds 10,000 shares of ASND stock, worth $1.3 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$1.3 Million
% of portfolio
0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$113.0 - $153.43 $1.13 Million - $1.53 Million
10,000 New
10,000 $1.49 Million
Q2 2019

Aug 07, 2019

SELL
$107.11 - $132.09 $1.66 Million - $2.05 Million
-15,500 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$62.15 - $129.99 $963,325 - $2.01 Million
15,500 New
15,500 $1.82 Million
Q4 2017

Feb 09, 2018

SELL
$31.98 - $40.38 $2.43 Million - $3.07 Million
-76,000 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$26.89 - $37.1 $2.04 Million - $2.82 Million
76,000
76,000 $2.76 Million

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.24B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.